Les Laboratoires SERVIER

Type: Company
Name: Les Laboratoires SERVIER
First reported Aug 18 2014 - Updated Aug 18 2014 - 1 reports

Servier and Galapagos' osteoarthritis alliance reaches new milestone

:02 in Pharmaceutical Company Product News Servier has announced that a second partial milestone has been reached in its osteoarthritis research alliance with Galapagos. The nomination of a new pre-clinical candidate has been completed by Galapagos, resulting ... [Published Zenopa - Aug 18 2014]
First reported Aug 15 2014 - Updated Aug 15 2014 - 1 reports

Xention awarded £1.4m TSB cash for heart medicines

Xention, a Cambridge-based biopharma business, has been awarded £1.4 million by the Technology Strategy Board to develop new medicines to combat irregular heartbeat.The UK’s innovation agency will co-fund the preclinical development of Xention’s novel ... [Published Business Weekly UK - Aug 15 2014]
First reported Aug 12 2014 - Updated Aug 12 2014 - 1 reports

European Commission fines six companies

BRUSSELS, Belgium—On July 9, the announced that it had imposed fines totaling €427.7 million (approximately $574 million) on the French pharmaceutical company Servier and five producers of generic medicines—namely, Niche/Unichem, Matrix (now part of Mylan), ... [Published Drug Discovery News - Aug 12 2014]
First reported Aug 07 2014 - Updated Aug 08 2014 - 2 reports

XOMA's (XOMA) CEO John Varian on Q2 2014 Results - Earnings Call Transcript

OperatorGood day ladies and gentlemen, and welcome to the XOMA Corporation’s Second Quarter 2014 Financial Results Conference. At this time, all participants are in a listen-only mode. Later, we will conduct a question-and-answer session, and instructions ... [Published Seeking Alpha - Aug 08 2014]
First reported Aug 07 2014 - Updated Aug 07 2014 - 2 reports

Pharma firm’s pre-tax profits up 37% to €66m as revenues top €600m

Pre-tax profits at the main Irish unit of pharmaceutical giant Servier increased 37% last year to €66.2m as revenues topped €600m.Numbers employed at Servier (Ireland) Industries’ Arklow plant — which was subject to a fresh €47m investment four years ... [Published Irish Examiner - Aug 07 2014]
First reported Aug 05 2014 - Updated Aug 05 2014 - 4 reports

BRIEF-Galapagos receives milestone in osteoarthritis alliance with Servier

6:38am BSTAug 5 (Reuters) - Galapagos Nv* Receives milestone in osteoarthritis alliance with servier* Today's payment remains undisclosed and contributes to group revenues in first half of 2014.* Galapagos is eligible to receive up to eur290 million in ... [Published Reuters UK - Aug 05 2014]
First reported Aug 05 2014 - Updated Aug 05 2014 - 2 reports

Interim results for the six months ended 30 June 2014

WINNERSH, UNITED KINGDOM -- (Marketwired) -- 08/05/14 -- (LSE: VER) (PINKSHEETS: VNLPY)Vernalis plc (LSE: VER) today announces its results for the six months ended 30 June 2014. Operational HighlightsCough Cold Commercial Pipeline:NCE Development Pip ... [Published Wall Street Select - Aug 05 2014]
First reported Aug 04 2014 - Updated Aug 04 2014 - 1 reports

The Commission fines Servier and five generic companies for curbing entry of cheaper versions of cardiovascular medicine

The European Commission has imposed fines totalling €427.7 million on the French pharmaceutical company Servier and five producers of generic medicines – namely, Niche/Unichem, Matrix (now part of Mylan), Teva, Krka and Lupin – for concluding a series ... [Published Lexology - Aug 04 2014]
First reported Aug 04 2014 - Updated Aug 04 2014 - 4 reports

Vernalis, Servier Reach Oncology Research Milestones

Vernalis and Servier have achieved two milestones in their oncology discovery collaborations, triggering a payment of €750K to Vernalis.The companies initiated their first collaboration in May 2007 utilizing Vernalis' fragment and structure-based drug ... [Published Contract Pharma - Aug 04 2014]
First reported Aug 04 2014 - Updated Aug 04 2014 - 1 reports

The Commission Fines Servier And Five Generic Companies For Curbing Entry Of Cheaper Versions Of Cardiovascular Medicine

The European Commission has imposed fines totalling €427.7 million on the French pharmaceutical company Servier and five producers of generic medicines – namely, Niche/Unichem, Matrix (now part of Mylan), Teva, Krka and Lupin – for concluding a series ... [Published JD Supra - Aug 04 2014]
First reported Aug 01 2014 - Updated Aug 01 2014 - 1 reports

European Commission fines Servier and five generic companies for curbing entry of cheaper versions of cardiovascular medicine

The European Commission has imposed fines totalling €427.7m (£340m) on the French pharmaceutical company Servier and five producers of generic medicines — namely Niche/Unichem, Matrix (now part of Mylan), Teva, Krka and Lupin — for concluding a series ... [Published The Lawyer - Aug 01 2014]
First reported Jul 24 2014 - Updated Jul 25 2014 - 2 reports

Xention awarded $2.4M from Technology Strategy Board to develop new medicines for atrial fibrillation

CAMBRIDGE, U.K.—Xention Ltd., a Cambridge-based biopharmaceutical company specializing in the discovery and development of ion channel-modulating drugs, announced today that it had secured £1.4 million co-funding (approximately $2.4 million) from the ... [Published Drug Discovery News - Jul 25 2014]

Quotes

O'Donnell paper. The paper "adds to the scientific evidence that low sodium consumption at levels recommended by public-health organizations may actually"
...We continue to execute on our novel targets, filling our pipeline with new opportunities," said Galapagos CEO Onno van de Stolpe. "Galapagos aims to deliver the 12 week data from DARWIN 1 with GLPG0634 in March 2015, starting a steady flow of Phase 2 readouts expected for GLPG0634 in rheumatoid arthritis and Crohn's next year and potentially triggering payments of $250 million from AbbVie. Galapagos is nearing some key valuation inflection points as it finishes up recruiting for these studies, with a healthy balance sheet to support further growth of our pipeline."
...Dr Patricia Belissa Mathiot, director of rheumatology innovation at Servier, said: "The achievement of this milestone reflects the strength and commitment in our relationship with Galapagos in the field of osteoarthritis. We look forward to continuing our collaboration to advance into clinical development." This comes after the firm also announced the achievement of two milestones in its oncology drug discovery collaboration with Vernalis earlier this m...
"And clear evidence suggests that the presence and severity of myocardial ischemia are important correlates of prognosis in stable CAD and possibly of the"

More Content

All (133) | News (107) | Reports (0) | Blogs (16) | Audio/Video (0) | Fact Sheets (2) | Press Releases (7)
sort by: Date | Relevance
Standards Needed for Salt Studies As 'Big Food'... [Published General Medicine eJournal - Aug 18 2014]
Galapagos cash position of €232 M provides soli... [Published Noodls - Aug 18 2014]
Servier and Galapagos' osteoarthritis alliance ... [Published Zenopa - Aug 18 2014]
Xention awarded £1.4m TSB cash for heart medicines [Published Business Weekly UK - Aug 15 2014]
Long-term aspirin use reduced risk for cancer, ... [Published Orthopedics Today - Aug 14 2014]
Association of Urinary Sodium and Potassium Exc... [Published New England Journal of Medicine - Aug 14 2014]
Urinary Sodium and Potassium Excretion, Mortali... [Published New England Journal of Medicine - Aug 14 2014]
GARY data provide comprehensive look at aortic ... [Published Orthopedics Today - Aug 13 2014]
Global and Chinese Diabetes Drugs Industry Repo... [Published Individual.com - Aug 13 2014]
European Commission fines six companies [Published Drug Discovery News - Aug 12 2014]
Stress Angina Edges Ischemia as a Solo Risk Pre... [Published Diabetes Care - Aug 12 2014]
Cambridge Index rises 1.8% [Published NW Brown Group Limited - Aug 11 2014]
Commission fines Servier over pay-for-delay set... [Published European Voice - Aug 08 2014]
MLV & Co Has Positive Outlook On XOMA [Published Benzinga.com - Aug 08 2014]
CLOVIS ONCOLOGY : Announces Second Quarter 2014... [Published 4 Traders - Aug 08 2014]
XOMA's (XOMA) CEO John Varian on Q2 2014 Result... [Published Seeking Alpha - Aug 08 2014]
Clovis Oncology's (CLVS) CEO Patrick Mahaffy on... [Published Seeking Alpha - Aug 08 2014]
Roche commits to Danish RNA lab, £3B London inc... [Published FierceBiotech - Aug 07 2014]
XOMA Highlights Recent Achievements and Reports... [Published Virtual Strategy Magazine - Aug 07 2014]
Clovis Oncology Announces Second Quarter 2014 O... [Published Wall Street Select - Aug 07 2014]
Extracorporeal Treatment for Long-Acting Barbit... [Published General Medicine eJournal - Aug 07 2014]
Galapagos Receives Milestone in Osteoarthritis ... [Published Technology Networks - Aug 07 2014]
Pharma firm’s pre-tax profits up 37% to €66m as... [Published Irish Examiner - Aug 07 2014]
Pharma firm’s pre-tax profits up 37% to €... [Published IrishExaminer.com Business - Aug 07 2014]
XOMA to Present at Two Upcoming Investor Confer... [Published BioSpace - Aug 06 2014]
EC fines French pharma giant and generic compan... [Published Legal Week Law - Aug 06 2014]
MacroGenics Provides Update on Corporate Progre... [Published Vision Monday - Aug 05 2014]
Vernalis ready for US lift-off in 2015 [Published Business Weekly UK - Aug 05 2014]
Galapagos achieves second partial milestone [Published Stock Market Wire - Aug 05 2014]
Interim results for the six months ended 30 Jun... [Published Wall Street Select - Aug 05 2014]
1 2 3 4 5
In Focus
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
Content Volume
Document Volume
Network
Network

Blogs

sort by: Date | Relevance
Vernalis and Servier Achieve Two Research Miles... [Published Marketwire - Breaking News Releases - Aug 04 2014]
WINNERSH, UNITED KINGDOM--(Marketwired - Aug 4, 2014) - Vernalis plc (LSE: VER) (PINKSHEETS: VNLPY) ...
Frontrunning: July 10 [Published Zero Hedge - Jul 10 2014]
Espirito Santo Financial Suspends Shares, Bonds on ESI Exposure ( BBG ) Europe Stocks Drop for Fifth Day as Espirito Santo Sinks ( BBG ) Espirito Santo Creditors Doubt Containment on Missed Payment ( BBG ) French Stocks Seen Extending Losses on Economy ...
Servier distort competition [Published PharmaGossip - Jul 09 2014]
BRUSSELS — The European Union's antitrust body is imposing a fine of 428 million euros ($580 million) on France's pharmaceutical company Servier and five producers of generic medicines for distorting competition. The 28-nation bloc's executive Commission ...
BioInvent Has Received Milestones from Bayer an... [Published Business Wire Science: Science News - Jul 07 2014]
LUND, Sweden--(BUSINESS WIRE)--Regulatory News: BioInvent (STO:BINV) BioInvent International (OMXS: BINV) today announced that it has received two separate milestone payments, together worth 1 MEuro, as a result of milestones being reached under collaborations ...
BioInvent Has Received Milestones from Bayer an... [Published Business Wire Health News - Jul 07 2014]
LUND, Sweden--(BUSINESS WIRE)--Regulatory News: BioInvent (STO:BINV) BioInvent International (OMXS: BINV) today announced that it has received two separate milestone payments, together worth 1 MEuro, as a result of milestones being reached under collaborations ...
1 2 3 4

Press Releases

sort by: Date | Relevance
Galapagos receives milestone in osteoarthritis ... [Published GlobeNewswire: Advertising News - Aug 05 2014]
MacroGenics' DART Candidate IND for Colorectal ... [Published GlobeNewswire: Acquisitions News - Jul 24 2014]
Galapagos receives EU2 million from osteoarthri... [Published GlobeNewswire: Acquisitions News - Mar 07 2014]
Celladon Announces Option Agreement With Servier [Published GlobeNewswire: Acquisitions News - Feb 24 2014]
Avalancha de fracturas de caderas afectará a As... [Published PR Newswire - Dec 12 2013]
1 2
Contact Us
Sales
Support


Freebase CC-BY Some image thumbnails are sourced from Freebase, licensed under CC-BY

Copyright (C) 2014 Silobreaker Ltd. All rights reserved.
The selection and placement of stories and images on any Silobreaker page are determined automatically by a computer program.
The time or date displayed reflects when an article was added to or updated in Silobreaker.